ANGELA JANICEK: Open Payments
NPI 1740949668 · GOODLETTSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 50 payments from 13 companies in 2025. Trend: 2023 $291 · 2024 $1,690 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $256 |
| E.R. Squibb & Sons, L.L.C. | 6 | $176 |
| Otsuka America Pharmaceutical, Inc. | 9 | $157 |
| Alkermes, Inc. | 6 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Axsome Therapeutics, Inc. | 6 | $80 |
| ABBVIE INC. | 4 | $77 |
| Noven Therapeutics, LLC | 3 | $48 |
| Corium, LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: FANAPT, COBENFY, ARISTADA, REXULTI, CAPLYTA, Auvelity, VRAYLAR, ABILIFY MAINTENA.
Industry payments across TN — which companies pay providers there.
